Filter News
Area of Research
- (-) Biology and Environment (25)
- (-) Neutron Science (28)
- (-) Nuclear Science and Technology (7)
- Advanced Manufacturing (18)
- Building Technologies (2)
- Clean Energy (93)
- Climate and Environmental Systems (1)
- Computational Biology (1)
- Computational Engineering (3)
- Computer Science (13)
- Fusion and Fission (5)
- Fusion Energy (4)
- Isotope Development and Production (1)
- Isotopes (3)
- Materials (78)
- Materials Characterization (1)
- Materials for Computing (13)
- Materials Under Extremes (1)
- Mathematics (1)
- National Security (15)
- Quantum information Science (4)
- Sensors and Controls (1)
- Supercomputing (57)
- Transportation Systems (2)
News Type
News Topics
- (-) 3-D Printing/Advanced Manufacturing (13)
- (-) Biomedical (15)
- (-) Computer Science (15)
- (-) Decarbonization (6)
- (-) Materials Science (20)
- (-) Security (2)
- Advanced Reactors (7)
- Artificial Intelligence (6)
- Big Data (3)
- Bioenergy (23)
- Biology (32)
- Biotechnology (7)
- Buildings (2)
- Chemical Sciences (9)
- Clean Water (3)
- Climate Change (17)
- Composites (4)
- Coronavirus (11)
- Critical Materials (1)
- Cybersecurity (1)
- Energy Storage (9)
- Environment (34)
- Frontier (1)
- Fusion (3)
- Grid (3)
- High-Performance Computing (9)
- Hydropower (3)
- Isotopes (5)
- Machine Learning (3)
- Materials (19)
- Mercury (1)
- Microscopy (5)
- Molten Salt (4)
- Nanotechnology (12)
- National Security (2)
- Net Zero (1)
- Neutron Science (64)
- Nuclear Energy (19)
- Partnerships (5)
- Physics (9)
- Polymers (1)
- Quantum Science (5)
- Simulation (5)
- Space Exploration (6)
- Summit (7)
- Sustainable Energy (16)
- Transformational Challenge Reactor (2)
- Transportation (6)
Media Contacts
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
As the rise of antibiotic-resistant bacteria known as superbugs threatens public health, Oak Ridge National Laboratory’s Shuo Qian and Veerendra Sharma from the Bhaba Atomic Research Centre in India are using neutron scattering to study how an antibacterial peptide interacts with and fights harmful bacteria.
The Department of Energy’s Oak Ridge National Laboratory is collaborating with industry on six new projects focused on advancing commercial nuclear energy technologies that offer potential improvements to current nuclear reactors and move new reactor designs closer to deployment.
Scientists at the Department of Energy’s Oak Ridge National Laboratory have created a recipe for a renewable 3D printing feedstock that could spur a profitable new use for an intractable biorefinery byproduct: lignin.
A team of scientists, led by University of Guelph professor John Dutcher, are using neutrons at ORNL’s Spallation Neutron Source to unlock the secrets of natural nanoparticles that could be used to improve medicines.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
With the production of 50 grams of plutonium-238, researchers at the Department of Energy’s Oak Ridge National Laboratory have restored a U.S. capability dormant for nearly 30 years and set the course to provide power for NASA and other missions.
For more than 50 years, scientists have debated what turns particular oxide insulators, in which electrons barely move, into metals, in which electrons flow freely.